Skip to main content
PMC home page
Gut logoLink to Gut
. 1995 Aug;37(2):177–181. doi: 10.1136/gut.37.2.177

Late mortality in elderly patients surviving acute peptic ulcer bleeding.

N Hudson 1, G Faulkner 1, S J Smith 1, M J Langman 1, C J Hawkey 1, R F Logan 1
PMCID: PMC1382713  PMID: 7557563

Abstract

Acute peptic ulcer bleeding is associated with a substantial short term mortality but it is generally assumed that in the modern era of effective medical treatment the longer term prognosis is good. This study evaluated 487 patients aged over 60 years who were discharged from Nottingham University and City Hospitals after admission for acute peptic ulcer bleeding during 1986-91 and 480 age and sex matched community controls. Follow up information was obtained from hospital and general practitioner records and from the National Health Service central register. Mortality was compared with control mortality and with rates expected for England and Wales. During a mean follow up of 34 months 142 (29%) of 487 patients died compared with 58 (12%) of 480 community controls and with 81.5 deaths expected (observed/expected (O/E) = 1.74, 95% confidence limits (CL) 1.5 to 2.1). Six years after admission the actuarial survival estimate was only 50% for ulcer patients compared with 76% for community controls and 69% expected. The increased mortality was similar in men and women and was greatest in the 60-74 year age group. Much of the excess mortality was accounted for by deaths from cancer (O/E 34/19.7 = 1.73; CL 1.2 to 2.4), from respiratory disease (O/E 28/10.9 = 2.57; CL 1.7 to 3.7), and in men from vascular disease (O/E 31/22.4 = 1.38; CL 0.9 to 2.0). Eight deaths resulted from recurrent ulcer complications and four deaths from gastric cancers undetected at the index admission. In conclusion, patients discharged after peptic ulcer bleeding had a substantially reduced life expectancy. The increased mortality was predominantly due to a variety of smoking related diseases rather than recurrent peptic ulcer complications. Deaths from recurrent peptic ulcer complications were infrequent and were less than reported in earlier years possibly reflecting prolonged and widespread used of H2 receptor antagonists.

Full text

PDF
177

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan R., Dykes P. A study of the factors influencing mortality rates from gastrointestinal haemorrhage. Q J Med. 1976 Oct;45(180):533–550. [PubMed] [Google Scholar]
  2. Armstrong C. P., Blower A. L. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 1987 May;28(5):527–532. doi: 10.1136/gut.28.5.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barer D., Ogilvie A., Henry D., Dronfield M., Coggon D., French S., Ellis S., Atkinson M., Langman M. Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. N Engl J Med. 1983 Jun 30;308(26):1571–1575. doi: 10.1056/NEJM198306303082606. [DOI] [PubMed] [Google Scholar]
  4. Borland J. L., Sr, Hancock W. R., Borland J. L., Jr Recurrent upper gastrointestinal hemorrhage in peptic ulcer. Gastroenterology. 1967 Apr;52(4):631–637. [PubMed] [Google Scholar]
  5. Carson J. L., Strom B. L., Soper K. A., West S. L., Morse M. L. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med. 1987 Jan;147(1):85–88. [PubMed] [Google Scholar]
  6. Clason A. E., Macleod D. A., Elton R. A. Clinical factors in the prediction of further haemorrhage or mortality in acute upper gastrointestinal haemorrhage. Br J Surg. 1986 Dec;73(12):985–987. doi: 10.1002/bjs.1800731213. [DOI] [PubMed] [Google Scholar]
  7. Coleman M., Douglas A., Hermon C., Peto J. Cohort study analysis with a FORTRAN computer program. Int J Epidemiol. 1986 Mar;15(1):134–137. doi: 10.1093/ije/15.1.134. [DOI] [PubMed] [Google Scholar]
  8. Daneshmend T. K., Hawkey C. J., Langman M. J., Logan R. F., Long R. G., Walt R. P. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ. 1992 Jan 18;304(6820):143–147. doi: 10.1136/bmj.304.6820.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gabriel S. E., Jaakkimainen L., Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991 Nov 15;115(10):787–796. doi: 10.7326/0003-4819-115-10-787. [DOI] [PubMed] [Google Scholar]
  10. Griffin M. R., Ray W. A., Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med. 1988 Sep 1;109(5):359–363. doi: 10.7326/0003-4819-109-5-359. [DOI] [PubMed] [Google Scholar]
  11. Harvey R. F., Langman M. J. The late results of medical and surgical treatment for bleeding duodenal ulcer. Q J Med. 1970 Oct;39(156):539–547. [PubMed] [Google Scholar]
  12. Jick H. Effects of aspirin and acetaminophen in gastrointestinal hemorrhage. Results from the Boston Collaborative Drug Surveillance Program. Arch Intern Med. 1981 Feb 23;141(3 Spec No):316–321. doi: 10.1001/archinte.141.3.316. [DOI] [PubMed] [Google Scholar]
  13. Katschinski B. D., Logan R. F., Davies J., Langman M. J. Audit of mortality in upper gastrointestinal bleeding. Postgrad Med J. 1989 Dec;65(770):913–917. doi: 10.1136/pgmj.65.770.913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Langman M. J., Cooke A. R. Gastric and duodenal ulcer and their associated diseases. Lancet. 1976 Mar 27;1(7961):680–683. doi: 10.1016/s0140-6736(76)92790-2. [DOI] [PubMed] [Google Scholar]
  15. Langman M. J., Weil J., Wainwright P., Lawson D. H., Rawlins M. D., Logan R. F., Murphy M., Vessey M. P., Colin-Jones D. G. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994 Apr 30;343(8905):1075–1078. doi: 10.1016/s0140-6736(94)90185-6. [DOI] [PubMed] [Google Scholar]
  16. Laporte J. R., Carné X., Vidal X., Moreno V., Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Catalan Countries Study on Upper Gastrointestinal Bleeding. Lancet. 1991 Jan 12;337(8733):85–89. doi: 10.1016/0140-6736(91)90744-a. [DOI] [PubMed] [Google Scholar]
  17. Logan R. F., Finlayson N. D. Death in acute upper gastrointestinal bleeding. Can endoscopy reduce mortality? Lancet. 1976 May 29;1(7970):1173–1175. doi: 10.1016/s0140-6736(76)91554-3. [DOI] [PubMed] [Google Scholar]
  18. Macintyre I. M., O'Brien F. Death from malignant disease after surgery for duodenal ulcer. Gut. 1994 Apr;35(4):451–454. doi: 10.1136/gut.35.4.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Piper J. M., Ray W. A., Daugherty J. R., Griffin M. R. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991 May 1;114(9):735–740. doi: 10.7326/0003-4819-114-9-735. [DOI] [PubMed] [Google Scholar]
  20. Shallcross T. M., Heatley R. V. Effect of non-steroidal anti-inflammatory drugs on dyspeptic symptoms. BMJ. 1990 Feb 10;300(6721):368–369. doi: 10.1136/bmj.300.6721.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Skander M. P., Ryan F. P. Non-steroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly. BMJ. 1988 Oct 1;297(6652):833–834. doi: 10.1136/bmj.297.6652.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Smart H. L., Langman M. J. Late outcome of bleeding gastric ulcers. Gut. 1986 Aug;27(8):926–928. doi: 10.1136/gut.27.8.926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Somerville K., Faulkner G., Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986 Mar 1;1(8479):462–464. doi: 10.1016/s0140-6736(86)92927-2. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES